$4.82
-0.21 (-4.17%)
Osiris Therapeutics, Inc. (NASDAQ:OSIR)
CAPS Rating:
A stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas.
RSS Headlines
Fool UK